Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Flora, López Simarro"'
Autor:
Domingo Orozco‐Beltrán, Sergio Cinza‐Sanjurjo, José Escribano‐Serrano, Flora López‐Simarro, Gonzalo Fernández, Antón Gómez García, Karine Ferreira de Campos, Marta Cedenilla Horcajuelo
Publikováno v:
Endocrinology, Diabetes & Metabolism, Vol 5, Iss 2, Pp n/a-n/a (2022)
Abstract Introduction Studies on treatment adherence to glucose‐lowering drugs among patients with type 2 diabetes (T2D) including concomitant treatment for other cardiovascular risk factors are scarce. We aimed to estimate the prevalence of good a
Externí odkaz:
https://doaj.org/article/941f7a9d42b64f70870b57062f6a57ff
Publikováno v:
Medicina Clínica (English Edition). 160:268-274
Publikováno v:
Medicina Clínica. 160:268-274
Autor:
Bogdan Vlacho, Flora López Simarro, Manel Mata-Cases, Sonia Miravet, José Escribano-Serrano, David Asensio, Xavi Cortes, Josep Franch-Nadal
Publikováno v:
Primary Care Diabetes. 16:760-767
To determine the degree and factors related to non-insulin antidiabetic drug (NIAD) adherence in people with type 2 diabetes mellitus (DM2) treated in primary carecentres in Spain.We did a cross-sectional study. During the study visit, variables rela
Autor:
José Javier Mediavilla Bravo, Cèlia Cols-Sagarra, María Belén González Mohíno Loro, Carlos Hernández-Teixidó, Judit Cañís-Olivé, Flora López-Simarro
Publikováno v:
Medicina de Familia. SEMERGEN. 48:54-62
Insulin treatment in type 2 diabetes mellitus patients is still essential and its usage has increased during recent years. Despite this, the level of control continues to be very poor. Insulin treatment is initiated with control levels above the reco
Autor:
Flora López Simarro
Publikováno v:
La insulina: un antes y un después en el tratamiento de la diabetes. :5-13
La insulina continúa siendo una piedra angular en el tratamiento de la diabetes mellitus tipo 2 (DM2), ya que la mayoría de las guías de práctica clínica (GPC) la recomiendan cuando no se consiguen los objetivos de control glucémicos con varios
Publikováno v:
Dipòsit Digital de la UB
Universidad de Barcelona
Universidad de Barcelona
Purpose Multimorbidity impacts quality of life. We constructed hypothyroidism comorbidity networks to identify positive and negative associations with other prevalent diseases. Methods We analyzed data of 285 342 patients with hypothyroidism from 3 1
Autor:
Ferran Moratalla-Navarro, Victor Moreno, Flora López-Simarro, Maria Estrella Barceló, Alba Aguado
Publikováno v:
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 43(12)
We constructed epilepsy multimorbidity networks to study associations with chronic conditions, and co-prescriptions and drug-disease networks to assess potential interactions. We conducted a population-based study in Catalonia, Spain, with electronic
Autor:
Irene Romera, Silvia Díaz-Cerezo, Tatiana Dilla, Antoni Sicras-Mainar, Esther Artime, Flora López-Simarro, Jesús Reviriego
Publikováno v:
Current Medical Research and Opinion. 36:1449-1456
To compare healthcare resource use (HRU) and annual costs in type 2 diabetes mellitus (T2DM) patients with poor glycaemic control and obesity versus good glycaemic control without obesity.Observational retrospective study based on the analysis of ele
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-12 (2020)
Dipòsit Digital de la UB
Universidad de Barcelona
Scientific Reports
Dipòsit Digital de la UB
Universidad de Barcelona
Scientific Reports
Multimorbidity has great impact on health care. We constructed multimorbidity networks in the general population, extracted subnets focused on common chronic conditions and analysed type 2 diabetes mellitus (T2DM) comorbidity network. We used electro